The US FDA has approved Bayer’s asundexian (Sunharbo) for use in combination with antiplatelet therapy to reduce the risk of stroke following recent mild-to-moderate non-cardioembolic ischaemic stroke ...
Tobemstomig Combinations in 1L Advanced Clear-Cell Renal Cell Carcinoma / cancer, cancer care, Cancer research, cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results